Author:
Olaoye Tejumola,Singh Kavita
Publisher
Springer International Publishing
Reference34 articles.
1. Maoz A, Matsuo K, Ciccone MA, Matsuzaki S, Klar M, Roman LD, et al. Molecular pathways and targeted therapies for malignant ovarian germ cell tumors and sex cord-stromal tumors: a contemporary review. Cancers (Basel). 2020;12(6):1398.
2. Canario R, Lima JP, Migali C, Tunariu N, George A, Kaye SB, et al. 877PD-clinical outcomes of recurrent ovarian granulosa cell tumours treated with letrozole: a 10-year retrospective case-series of the Royal Marsden Hospital. Ann Oncol. 2014;25(4):iv305.
3. Korach J, Perri T, Beiner M, Davidzon T, Fridman E, Ben-Baruch G. Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. Int J Gynecol Cancer. 2009;19(5):830–3.
4. Li J, Chu R, Chen Z, Meng J, Yao S, Song K, Kong B. Progress in the management of ovarian granulosa cell tumor: a review. Acta Obstet Gynecol Scand. 2021;100(10):1771–8.
5. Dridi M, Chraiet N, Batti R, Ayadi M, Mokrani A, Meddeb K, Yahiaoui Y, Raies H, Mezlini A. Granulosa cell tumor of the ovary: a retrospective study of 31 cases and a review of the literature. Int J Surg Oncol. 2018;2018:4547892.